Poznań University of Medical Sciences and Pikralida sp. z o. o. conduct a project no. TANGO-IV-C/0012/2019 named Development of an innovative combined preparation dedicated for the treatment of hypertension.
The project is co-financed from the state budget within the TANGO IV program organised by the National Centre for Research and Development.
The aim of the project is to develop innovative, combination formulations of the medicinal products dedicated for the treatment of hypertension containing an active pharmaceutical ingredient. The development stages for the presented pharmaceutical formulations will cover: obtainment of the stable form of an amorphic API, studies of the physical and chemical stability, and the compatibility of the tablet sets for the respective API/API-API and excipients combinations in relation to the selection of the formulation method, obtainment of the innovative prototypes of the combination pharmaceutical formulations, and the development of the scale-up method.
- Project budget: 2,858,000.00 PLN
- Co-financing of the project from the state budget: 2,440,100.00 PLN
- Project timeline: 01.01.2021 – 31.12.2023
Co-financed projects:
Project no. POIR.01.01.01-00-0072/21
Development of an innovative pilot line and its validation under real conditions using synthesis process of a model active pharmaceutical ingredient.
Project no. POIR.01.01.01-00-0235/20
Utilisation of a matrix metalloprotease inhibitor to develop an innovative therapeutic method that prevents the development of post-traumatic and post-stroke epilepsy.
Project no. POIR.04.01.04-00-0063/20-00
Development of the innovative formulation of the combination drug dedicated for the geriatric patients in pain pharmacotherapy
Project no. RPWP.01.02.00-30-0047/19-00
Establishment of a R&D Laboratory of Super Generic Drugs.